Literature DB >> 7138234

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

D S Charney, C E Riordan, H D Kleber, M Murburg, P Braverman, D E Sternberg, G R Heninger, D E Redmond.   

Abstract

Clonidine hydrochloride and naltrexone hydrochloride, given in combination, were found to provide a safe, effective, and extremely rapid treatment of abrupt withdrawal from methadone hydrochloride therapy. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, ten (91%) of 11 patients were able to withdraw completely from methadone therapy by the end of a six-day period. Six days of clonidine hydrochloride treatment, with a peak mean dose of 2.9 mg/day on treatment day 2, attenuated the withdrawal-inducing effects of naltrexone. Naltrexone hydrochloride was gradually increased from an initial 1-mg dose on treatment day 2 to 50-mg maintenance dose on treatment day 5 without an associated increase in withdrawal symptoms. Clonidine significantly decreased BP without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, and muscular aching were most resistant to treatment, but at discharge most patients were completely asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138234     DOI: 10.1001/archpsyc.1982.04290110077013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  12 in total

1.  Opiate withdrawal: inpatient versus outpatient programmes.

Authors:  C Brewer
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

2.  Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat.

Authors:  D S Rohde; A I Basbaum
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

3.  Drug addicts and the GP.

Authors:  C Brewer
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

4.  [The drug addict in prison: Medical response and its limitations].

Authors:  R Jeanmonod; T Harding
Journal:  Soz Praventivmed       Date:  1988

Review 5.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

6.  Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine.

Authors:  L Antkiewicz-Michaluk; J Michaluk; I Romańska; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.

Authors:  J R Taylor; J D Elsworth; E J Garcia; S J Grant; R H Roth; D E Redmond
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Differential mechanisms in the acquisition and expression of heroin-induced place preference.

Authors:  T H Hand; L Stinus; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 9.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathi Peindl; David A Gorelick; Li-Tzy Wu; Edward Gottheil
Journal:  Addict Biol       Date:  2008-08-19       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.